Tactile Systems Technology, Inc. (TCMD) Stock Price
TCMDStock
$23.16+75.85%52W
Market Cap$524.63M
P/E28.61x
PEG Ratio17.79
Div yield—
Beta0.80
TCMD Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-31.09%
Price vs S&P 500 (4W)-23.77%
PEG Ratio17.79
VGM Score69.56
P/E Ratio (Annual)28.61x
TCMD Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $0.17 | $0.36 | +111.76%(+$0.19) | |
| Q1 2026 | -$0.04 | $0.00 | +106.86%(+$0.04) | |
| Q4 2025 | $0.45 | $0.46 | +3.37%(+$0.02) | |
| Q3 2025 | $0.17 | $0.36 | +106.90%(+$0.19) | |
| Q2 2025 | $0.14 | $0.14 | -3.45%(-$0.01) |
TCMD Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.18
4.27
4.27
4.27
Industry Peers — Surgical & Medical Instruments(140)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
TCMDTactile Systems Technology, Inc. | B | B | C | $23.16 |
| SYKStryker Corporation | C | B | C | $330.69 |
| MMM3M Company | C | D | C | $174.34 |
| BSXBoston Scientific Corp. | C | B | D | $46.84 |
| BDXBecton, Dickinson and Co. | B | D | B | $189.52 |
| MDLNMedline Inc. Class A common stock | C | D | C | $35.28 |
| RMDResMed Inc. | C | B | B | $240.33 |
| DXCMDexCom, Inc. | D | B | B | $90.82 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $337.47 |
| SOLVSolventum Corporation | C | C | B | $91.12 |
| BAXBaxter International Inc. | B | D | B | $26.13 |
About Tactile Systems Technology, Inc.
Tactile Systems Technology develops home-based medical devices for chronic disease management. The company's proprietary platforms include FlexiTouch for lymphedema treatment and AcuTouch for chronic venous insufficiency, along with additional solutions for chronic swelling. These wearable and home-based therapies enable patients to manage their conditions outside clinical settings.